Skip to main content
. 2018 Nov 1;19:302. doi: 10.1186/s12882-018-1099-7

Fig. 1.

Fig. 1

Flow diagram of the clinical trial set-up. This trial is a multicenter, double-blind, randomized, placebo-controlled trial. After obtaining informed consent, registration and allocation is conducted. After rituximab treatment, mycophenolate mofetil or placebo is administered and the treatment key is opened following completion of the entire clinical trial